QMF149 (Indacaterol Acetate/Mometasone Furoate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for QMF149 (Indacaterol Acetate/Mometasone Furoate), covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma [Phase 3]